Connect with us
DAPA Banner

Crypto World

UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges

Published

on

UnitedHealth Group Incorporated (UNH)

Key Takeaways

  • Shares began trading at $277.32, significantly below the 52-week peak of $606.36
  • Wall Street firms reduced price targets — JPMorgan to $389, Truist to $370, UBS to $410
  • Weiss Ratings issued a Sell recommendation in early March
  • Fourth-quarter EPS of $2.11 slightly exceeded forecasts; revenue climbed 12.3% to $113.73 billion
  • Consensus rating stays at Moderate Buy with a $372.13 mean target according to MarketBeat

UnitedHealth Group (UNH) has experienced significant turbulence recently. Shares opened Monday’s session at $277.32, trading considerably beneath both the 50-day moving average of $297.19 and the 200-day moving average of $324.39.

UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated (UNH)

This marks a substantial decline from the 52-week peak of $606.36. The stock’s 52-week bottom rests at $234.60.

The healthcare giant’s market capitalization presently registers at $251.71 billion, accompanied by a price-to-earnings multiple of 21.02 and a beta of 0.41.

The company maintains a debt-to-equity ratio of 0.72, while both current and quick ratios stand at 0.79.

During January, UnitedHealth disclosed fourth-quarter earnings of $2.11 per share, marginally surpassing the consensus forecast of $2.09. Revenue totaled $113.73 billion, representing a 12.3% year-over-year increase and slightly exceeding Wall Street projections.

However, the Q4 EPS figure represents a significant decline compared to the $6.81 posted during the corresponding quarter last year.

Advertisement

Wall Street Firms Reduce Price Targets

Multiple prominent investment banks have decreased their price objectives in recent weeks.

JPMorgan reduced its target from $425 down to $389, Morgan Stanley adjusted downward from $411 to $409, and UBS lowered its projection from $430 to $410. Truist executed the most aggressive reduction, dropping from $410 to $370. Despite these cuts, all four firms preserved Buy or Overweight recommendations.

Weiss Ratings took a more bearish stance, downgrading UNH from Hold to Sell during early March.

According to MarketBeat, the current consensus rating remains at Moderate Buy, featuring 17 Buy recommendations, 8 Hold ratings, and 2 Sell ratings. The mean 12-month price objective stands at $372.13 — suggesting approximately 34% potential upside from present levels.

Advertisement

Regarding institutional investors, significant movements have occurred. Wealth Enhancement Advisory Services reduced its position by 40.6% during Q4, liquidating 170,643 shares. Conversely, Norges Bank, Berkshire Hathaway, and Capital Research Global Investors all increased or established new positions throughout 2024. Institutional investors collectively control 87.86% of outstanding shares.

Ongoing Regulatory Concerns

Department of Justice investigations concerning Medicare Advantage reimbursement methodologies continue creating headwinds for investor sentiment. While the company has secured at least one favorable legal outcome in that matter, broader regulatory pressures surrounding prior-authorization procedures and coverage denial practices persist.

Executives have previously disclosed intentions to reduce certain Medicare Advantage membership and adjust product pricing in response to changing cost dynamics.

Management provided fiscal year 2026 EPS guidance of approximately $17.75. Wall Street analysts currently project full-year EPS of $29.54 for the ongoing fiscal year.

Advertisement

UNH distributed a quarterly dividend of $2.21 per share on March 17, translating to an annualized yield of approximately 3.2%. The current payout ratio stands at 67.02%.

On a constructive note, UnitedHealth recently unveiled a nationwide expansion of its doula benefit initiative, which may enhance member retention and drive improved outcomes within its value-based care framework.

Source link

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Crypto World

Glider, Ondo Launch Custom Tokenized Stock Portfolios Without Brokers

Published

on

Glider, Ondo Launch Custom Tokenized Stock Portfolios Without Brokers

Glider and Ondo Finance have introduced a platform to let retail investors build and automate custom portfolios of tokenized US stocks, offering direct exposure to equities without a brokerage account.

According to the announcement, the platform allows users to create personalized baskets of onchain stocks that track real-world assets, removing the need for wallets, gas fees or manual transaction management.

Glider co-founder and CEO Brian Huang told Cointelegraph that unlike traditional exchange-traded funds, which bundle assets into fixed products, the platform lets users construct index-like portfolios with custom weightings that are automatically maintained, avoiding reliance on pooled products.

The platform automatically executes and rebalances these portfolios, allowing users to gain exposure to tokenized equities without managing individual trades. The assets track underlying shares and can be traded beyond standard market hours.

Advertisement

Huang added that the model avoids the liquidity constraints that have limited earlier tokenized ETF offerings. He said:

“This is the first time direct indexing has been offered for onchain stocks… The problem that all ETFs have had on chain is liquidity. There’s no liquidity constraint on Glider because these are directly indexed. You hold the underlying assets and tap into their underlying liquidity.”

Tokenized stocks on Ondo’s platform are designed to mirror the price of their underlying shares and can be transferred and traded onchain, while Glider automates portfolio construction and rebalancing without requiring users to execute transactions manually.

The initial rollout will focus on tokenized US equities, with plans to expand into additional asset classes such as commodities, while also introducing features that allow users to lend positions and generate yield on their holdings.

Advertisement

A spokesperson for Ondo said the platform is not currently available to US users but said the company holds several SEC registrations, positioning it for a potential future launch in the United States.

Related: Binance adds Ondo’s tokenized stocks in latest RWA push

Tokenized stocks grow alongside evolution of crypto ETPs

Tokenized equities and crypto exchange-traded products (ETPs) have both expanded rapidly over the past year. 

Data from RWA.xyz shows the total value of tokenized real-world assets (RWA) has grown sharply to around $26.5 billion, up from around $7.5 billion the same time last year. Among the RWAs onchain, around $908.5 million are tokenized stocks.

Advertisement
Tokenized real-world assets. Source: RWA.xyz

At the same time, crypto ETPs have moved beyond spot Bitcoin (BTC) and Ether (ETH) funds, with issuers increasingly exploring more complex and actively managed products.

In February, crypto ETP issuer 21Shares launched a new product offering European investors exposure to a preferred stock issued by Michael Saylor’s Strategy, the largest public holder of Bitcoin. The 21Shares Strategy Yield ETP is available to institutional and retail investors and offers a dividend linked to Strategy’s Bitcoin holdings.

21Shares president Duncan Moir told Cointelegraph the product improves access to Strategy’s STRC preferred stock, which is not widely available or easily cross-listed, while expanding distribution and liquidity through its ETP structure.

He added that the structure also simplifies tax treatment for European investors by handling reporting and withholding at the product level. Moir said:

It’s probably the product we’re seeing the most interest in across multiple regions. From the day we launched it, we’ve had more inbound inquiries to the sales team than for any crypto product, to be honest.

Earlier this month, BlackRock expanded its crypto lineup with a Nasdaq-listed product tied to Ethereum staking. The iShares Staked Ethereum Trust ETF (ETHB) provides spot Ether exposure while generating potential monthly income by staking a portion of its holdings.

Advertisement

However, BlackRock’s head of digital assets, Robert Mitchnick, said the asset management behemoth plans to remain cautious in expanding its crypto ETF offerings, despite growing interest in more complex structures.

Magazine: Big Questions: Can Bitcoin save you from the dreaded Cantillon Effect?